Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. United Orthopedic's Revenue for the
three
months ended in Mar. 2026 was NT$1,494 Mil. United Orthopedic's average Accounts Receivable for the
three
months ended in Mar. 2026 was NT$1,350 Mil.
Hence, United Orthopedic's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.11.
United Orthopedic (ROCO:4129) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
United Orthopedic Receivables Turnover Related Terms
United Orthopedic Receivables Turnover Historical Data
* Premium members only.
The historical data trend for United Orthopedic's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4129 vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, United Orthopedic's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Orthopedic Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, United Orthopedic's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where United Orthopedic's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Orthopedic (ROCO:4129) has a Receivables Turnover of 1.11 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on United Orthopedic and its competitors. According to the industry distribution chart, United Orthopedic ranks #541 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 66.7%.
Is United Orthopedic's Receivables Turnover too high?
United Orthopedic's current Receivables Turnover is 1.11. The Medical Devices & Instruments industry median Receivables Turnover is 5.58. United Orthopedic's value of 1.11 is 80.1% below this industry median. Based on the distribution chart, United Orthopedic ranks #541 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, United Orthopedic has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Orthopedic's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, United Orthopedic ranks #541 out of 811 companies for Receivables Turnover. This places United Orthopedic in the lower half of its industry. The industry median Receivables Turnover is 5.58. United Orthopedic's value of 1.11 is 80.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.58, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Orthopedic's current Receivables Turnover of 1.11 is 80.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on United Orthopedic and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Orthopedic's current Receivables Turnover is 1.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Orthopedic stock overvalued right now?
Based on GuruFocus' analysis, United Orthopedic (ROCO:4129) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$129.33, compared to a current price of NT$88.10 — trading 31.9% below its estimated fair value. The current Receivables Turnover is 1.11 and 80.1% below the Medical Devices & Instruments industry median of 5.58. United Orthopedic's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For United Orthopedic (ROCO:4129), the current Receivables Turnover is 1.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is United Orthopedic (ROCO:4129) Overvalued in 2026?
Based on GuruFocus' analysis, United Orthopedic stock appears to be undervalued.
The current stock price of NT$88.10 is trading 31.9% below its estimated GF Value™ of NT$129.33.
GuruFocus considers United Orthopedic to be Significantly Undervalued.
Key valuation signals for ROCO:4129:
Receivables Turnover: 1.11
GF Value™: NT$129.33 vs. price of NT$88.10 (31.9% below fair value)
Industry Position: 80.1% below the Medical Devices & Instruments median (#541 of 811)
No single metric tells the full story. See the ROCO:4129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
United Orthopedic Corp is engaged in the research, development, production, manufacturing, and sales of orthopedic implants, orthopedic surgical instruments and manufacturing equipment, special metal and plastics materials, as well as the import and export of the aforementioned products. Its products include Hip System, Knee System, and Limb Salvage.
76GF Score
Get the complete analysis for ROCO:4129
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4129 has been successfully added to your 
